TLR3 dsRNA agonist inhibits growth and invasion of HepG2.2.15 HCC cells

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 200-206

  Chen, Li ^a   Xu, Yu Yin ^b   Zhou, Jia Ming ^b   Wu, Yuan Yuan ^b   E, Qun ^b   Zhu, Yuan Yuan ^c  

^a NANTONG TUMOR HOSPITAL   (China)

^b NANTONG UNIVERSITY   (China)

^c Biomics (Nantong) Co Ltd   (China)

Author keywords

Apoptosis; DsRNA; Hepatocellular carcinoma; Proliferation; TLR3

Indexed keywords

BIOLOGICAL MARKER; BM 06; CHOLECYSTOKININ OCTAPEPTIDE; DOUBLE STRANDED RNA; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL ASSAY; CELL NUCLEUS; CELL STRAIN HEPG2; CELL STRAIN HEPG2.2.15; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; FLOW CYTOMETRY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; HEP G2 CELLS; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; NF-KAPPA B; POLY I-C; RNA, DOUBLE-STRANDED; TOLL-LIKE RECEPTOR 3; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; VIRUS RELEASE;

EID: 84861538048     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1791     Document Type: Article

References (25)

1. Bosch FX, Ribes J and Borras J: Epidemiology of primary liver cancer. Semin Liver Dis 19: 271-285, 1999. (Pubitemid 29488770)
2. Kew MC: Epidemiology of hepatocellular carcinoma. Toxicology 181-182: 35-38, 2002.
3. Wild CP and Hall AJ: Primary prevention of hepatocellular carcinoma in developing countries. Mutat Res 462: 381-393, 2000. (Pubitemid 30190243)
4. Yoo HY, Patt CH, Geschwind JF and Thuluvath PJ: The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 21: 4329-4335, 2003. (Pubitemid 46621808)
5. Alexopoulou L, Holt AC, Medzhitov R and Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738, 2001. (Pubitemid 33009951)
6. Kariko K, Bhuyan P, Capodici J, Ni H, Lubinski J, Friedman H and Weissman D: Exogenous siRNA mediates sequence-independent gene suppression by signaling through toll-like receptor 3. Cells Tissues Organs 177: 132-138, 2004. (Pubitemid 39279469)
7. Kaiser WJ and Offermann MK: Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol 174: 4942-4952, 2005. (Pubitemid 40514460)
8. Han KJ, Su X, Xu LG, Bin LH, Zhang J and Shu HB: Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J Biol Chem 279: 15652-15661, 2004. (Pubitemid 38618967)
9. Khvalevsky E, Rivkin L, Rachmilewitz J, Galun E and Giladi H: TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. J Cell Biochem 100: 1301-1312, 2007. (Pubitemid 46480411)
10. Salaun B, Coste I, Rissoan MC, Lebecque SJ and Renno T: TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 176: 4894-4901, 2006.
11. Salaun B, Lebecque S, Matikainen S, Rimoldi D and Romero P: Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 13: 4565-4574, 2006.
12. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M Jr and Lemon SM: Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 102: 2992-2997, 2005. (Pubitemid 40299904)
13. Otsuka M, Kato N, Moriyama M, Taniguchi H, Wang Y, Dharel N, Kawabe T and Omata M: Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses. Hepatology 41: 1004-1012, 2005. (Pubitemid 40593908)
14. Gale M Jr and Foy EM: Evasion of intracellular host defence by hepatitis C virus. Nature 436: 939-945, 2005.
15. Ferreon JC, Ferreon AC, Li K and Lemon SM: Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. J Biol Chem 280: 20483-20492, 2005. (Pubitemid 40776748)
16. Schröder M and Bowie AG: TLR3 in antiviral immunity: key player or bystander? Trends Immunol 26: 462-468, 2005. (Pubitemid 41139255)
17. Zorde-Khvalevsky E, Abramovitch R, Barash H, Spivak-Pohis I, Rivkin L, Rachmilewitz J, Galun E and Giladi H: Toll-like receptor 3 signaling attenuates liver regeneration. Hepatology 50: 198-206, 2009.
18. Bergé M, Bonnin P, Sulpice E, Vilar J, Allanic D, Silvestre JS, Lévy BI, Tucker GC, Tobelem G and Merkulova-Rainon T: Small interfering RNAs induce target independent inhibition of tumor growth and vasculature remodeling in a mouse model of hepatocellular carcinoma. Am J Pathol 177: 3192-3201, 2010.
19. Vercammen E, Staal J and Beyaert R: Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 21: 13-25, 2008. (Pubitemid 351160008)
20. Karikó K, Ni H, Capodici J, Lamphier M and Weissman D: mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279: 12542-12550, 2004. (Pubitemid 38445825)
21. Wang B, Trippler M, Pei R, Lu M, Broering R, Gerken G and Schlaak JF: Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication. J Hepatol 51: 1037-1045, 2009.
22. Isogawa M, Robek MD, Furuichi Y and Chisari FV: Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 79: 7269-7272, 2005. (Pubitemid 40677357)
23. Wu J, Lu M, Meng Z, Trippler M, Broering R, Szczeponek A, Krux F, Dittmer U, Roggendorf M, Gerken G and Schlaak JF: Toll-like receptor-mediated control of HBV replication by non-parenchymal liver cells in mice. Hepatology 46: 1769-1778, 2007.
24. Kanda T, Steele R, Ray R and Ray RB: Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes. J Virol 81: 12375-12381, 2007. (Pubitemid 350085851)
25. Kleinman ME, Yamada K, Takeda A, et al: Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452: 591-597, 2008. (Pubitemid 351483358)